Background The presentation and outcome of differentiated thyroid carcinoma (DTC) in
developing countries are different from the developed nations. We report the …

Purpose Poorly differentiated thyroid carcinoma (PDTC) patients have worse outcomes than
patients with differentiated thyroid carcinoma (DTC), but the implication of poorly …

Background: The American Joint Committee on Cancer Cancer Staging System for
differentiated thyroid cancer has been recently revised. The purpose of this study was to …

Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all
thyroid cancers. Our objective is to report outcomes in a large series of patients with PDTC …

Differentiated thyroid carcinoma (DTC) is usually associated with a favorable prognosis.
Nevertheless, up to 30% of patients present a local or distant recurrence. The aim of this …

Many risk factors have been identified in differentiated thyroid cancer, with them, some
prognostic scores have been designed to asign the risk of recurrence and survival. In …

Background and Objectives To present treatment outcomes and prognostic factors for
surgical management of locally advanced differentiated thyroid cancer (DTC). Methods …

Differentiated thyroid carcinoma is a relatively indolent disease. Despite the usually
favorable prognosis, differentiated thyroid cancer is fatal in some patients. In the past …

The understanding of the prognostic factors and risk groups is crucial in the management of
well differentiated thyroid cancer. The important prognostic factors are age, grade of tumor …

Objectives WDTC (papillary and follicular thyroid cancer) make up around 90% of all thyroid
tumours. Overall, the prognosis in patients with WDTC is excellent. However, there are small …